US › Healthcare

Alpha Teknova Inc (TKNO)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.81-0.89%

Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue

$12.7M

Revenue YoY

+21.5%

Net profit

$-3.5M

EPS

$-0.06

EPS estimate

$-0.06

Net margin

-27.5%

EPS came in at -0.06 against a street estimate of -0.06 — a beat of 0.0%.

Key statistics

Market cap

$454.7M

Forward P/E

0.0

P/B

7.23

Book value

$1.28

EPS (TTM)

$-0.31

52-week high

$9.48

52-week low

$1.91

50-day MA

$7.71

200-day MA

$4.92

Beta

0.96

Analyst view

Analysts rate Alpha Teknova Inc a strong buy (7 buy, 1 hold, 0 sell out of 8) with an average price target of $9.67.

Shareholding

Insiders

8.10%

Institutions

76.05%

Largest institutional holders

Fund	Stake
Royce & Associates, LP	3.09%
Vanguard Capital Management, LLC	3.01%
Roubaix Capital, LLC	2.94%
BlackRock Inc	1.64%
UBS Group AG	1.18%
Conestoga Capital Advisors, LLC	0.59%
Geode Capital Management, LLC	0.58%
Bank of America Corp	0.48%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alpha Teknova Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.